What do I mean by HIV commodities? We want to start local production of condoms because as we speak, we’re importing condoms.

ALAN ROSSI SILVA argues that Gilead’s HIV prevention drug, while promising, highlights systemic failures in the ...

In a study of more than 3,000 participants, Gilead's twice-yearly lenacapavir delivered a 96% reduction in HIV infections compared with background HIV incidence.

Leerink Partners analyst Daina Graybosch has maintained their neutral stance on GILD stock, giving a Hold rating on September 12. “Daina ...

For those with $200 to spare that isn't being saved for emergencies, let's consider two healthcare stocks within that budget ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Gilead Sciences rose 2% in early trading, after the biotech reported positive data for a long-acting HIV prevention drug that promises to be a big seller. The drug, called lenacapavir, was 96% ...

Dr Bianca Ogden and Hashan De Silva share the companies and trials they find interesting in the constantly innovating biotech ...

South Africa is one of 14 countries that will be financially supported by the Africa CDC and WHO from this month until ...

StudyFinds' Dr. Faith Coleman reveals what doctors and scientists have learned from the COVID pandemic as they prepare for future outbreaks.

Today’s edition: The Centers for Disease Control and Prevention issued a food safety alert because of a salmonella outbreak ...

frequently within the context of commercial sex work (Shankle 2006). Needle injection practices may also increase risk for HIV through unsafe injection of recreational drugs or substances to alter ...